每经AI快讯，博士眼镜（SZ 300622，收盘价：36.75元）发布公告称，2025年8月28日，博士眼镜接受 长江证券等投资者调研，公司董事会秘书、副总经理丁芸洁等人参与接待，并回答了投资者提出的问 题。 2025年1至6月份，博士眼镜的营业收入构成为：零售行业-线上占比83.21%，零售行业-线下占比 16.79%。 截至发稿，博士眼镜市值为84亿元。 每经头条（nbdtoutiao）——申请超2万份，已开出41家，加盟海底捞，你要准备多少钱？1000万元不算 多，真实"账单"公布 （记者 王晓波） ...

Group 1: Financial Performance - The company's revenue and profit continued to achieve positive growth during the reporting period, with a significant increase in sales efficiency year-on-year [2] - Functional lens sales increased by 26.58% year-on-year, accounting for 39.82% of total lens sales [2] - The sales volume of defocus lenses grew by 18.35%, representing 15.42% of total lens sales [3] Group 2: Marketing and Sales Strategies - The company enhanced consumer education and marketing for functional lenses through festive promotions, themed marketing, and collaborations, expanding brand reach [2] - A comprehensive online-offline integration strategy was implemented, utilizing platforms like Tmall, Douyin, and Xiaohongshu to attract target customers and improve store conversion rates [3] - The introduction of a "99 paid membership" program focused on "accidental damage protection" to enhance customer service experience and increase customer loyalty [3] Group 3: Store Development and Customer Experience - Over 150 retail stores have been upgraded to include smart glasses display areas, creating immersive shopping experiences to boost foot traffic conversion [3]

Market Overview - On August 28, the professional chain sector experienced a decline of 0.46%, with Huazhi Wine leading the drop [1] - The Shanghai Composite Index closed at 3843.6, up 1.14%, while the Shenzhen Component Index closed at 12571.37, up 2.25% [1] Individual Stock Performance - Tianyin Holdings (000829) closed at 10.60, up 1.44% with a trading volume of 252,300 shares [1] - Aishide (002416) closed at 12.60, up 1.04% with a trading volume of 337,200 shares [1] - Jifeng Technology (300022) closed at 8.72, down 0.11% with a trading volume of 228,200 shares [1] - Haiziwang (301078) closed at 12.43, down 1.35% with a trading volume of 769,100 shares [1] - Doctor Glasses (300622) closed at 36.75, down 1.47% with a trading volume of 215,400 shares [1] - Aiying Room (603214) closed at 19.15, down 1.69% with a trading volume of 84,300 shares [1] - Huazhi Wine (300755) closed at 17.90, down 3.24% with a trading volume of 156,600 shares [1] Capital Flow Analysis - The professional chain sector saw a net outflow of 329 million yuan from main funds, while retail investors contributed a net inflow of 278 million yuan [1] - The table indicates that Huazhi Wine had a main fund net inflow of over 1.62 million yuan, but a net outflow of 23.4 million yuan from retail investors [2] - Jifeng Technology experienced a main fund net outflow of 145,400 yuan, with retail investors contributing a net inflow of 27.28 million yuan [2] - Doctor Glasses had a significant main fund net outflow of 75.03 million yuan, while retail investors contributed a net inflow of 116 million yuan [2] - Haiziwang faced a main fund net outflow of 162 million yuan, with retail investors contributing a net inflow of 125 million yuan [2]

Core Insights - The company reported a total revenue of 686 million yuan for the first half of 2025, ranking 6th among disclosed peers [1] - The net profit attributable to shareholders was 56.03 million yuan, ranking 4th among disclosed peers [1] - The net cash inflow from operating activities was 128 million yuan, ranking 4th among disclosed peers, but decreased by 6.33 million yuan compared to the same period last year, a decline of 4.70% [1] Financial Metrics - The latest debt-to-asset ratio is 33.99% [3] - The latest gross profit margin is 54.65%, down 3.43 percentage points from the previous quarter and down 3.44 percentage points year-on-year [3] - The latest return on equity (ROE) is 6.87%, a decrease of 0.23 percentage points compared to the same period last year [3] - The diluted earnings per share (EPS) is 0.25 yuan [3] - The latest total asset turnover ratio is 0.55 times, ranking 5th among disclosed peers [3] - The latest inventory turnover ratio is 1.51 times, also ranking 5th among disclosed peers [3] Shareholder Information - The number of shareholders is 53,800, with the top ten shareholders holding a total of 102 million shares, accounting for 44.60% of the total share capital [3] - The top ten shareholders and their holdings are as follows: - LOUISA FAN: 21.2 million shares - ALEXANDER LIU: 19.1 million shares - Jiangxi Jiangnan Dao Enterprise Management Co., Ltd.: 1.06 million shares - Industrial and Commercial Bank of China - GF Innovation Upgrade Flexible Allocation Mixed Securities Investment Fund: 0.85 million shares - China Construction Bank - Minsheng Jianyin Continuous Growth Mixed Securities Investment Fund: 0.66 million shares - Yang Qiu: 0.37 million shares - China Merchants Bank - GF Value Core Mixed Securities Investment Fund: 0.33 million shares - Liu Kaiyue: 0.31 million shares - Xu Liming: 0.31 million shares - China Life Insurance - Universal - Guoshou Ruian: 0.29 million shares [3]

Core Viewpoint - The company, BoShi Optical, announced the appointment of Chen Qianqian as the securities affairs representative to assist the board secretary in fulfilling responsibilities, effective from the date of board approval until the end of the current board's term [1] Group 1 - The fifth meeting of the fifth board of directors will be held on August 26, 2025, to review the appointment proposal [1] - The appointment of Chen Qianqian is aimed at enhancing the company's governance and compliance in securities affairs [1]

Core Viewpoint - The company, Dr. Optical (300622.SZ), reported a revenue of 686 million yuan for the first half of 2025, reflecting a year-on-year growth of 14.22% [1] - The net profit attributable to shareholders reached 56.03 million yuan, marking a year-on-year increase of 6.97% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 49.65 million yuan, showing an 8.24% year-on-year growth [1] - The basic earnings per share stood at 0.25 yuan [1] Financial Performance - Revenue for the first half of 2025: 686 million yuan, up 14.22% year-on-year [1] - Net profit attributable to shareholders: 56.03 million yuan, up 6.97% year-on-year [1] - Net profit after deducting non-recurring items: 49.65 million yuan, up 8.24% year-on-year [1] - Basic earnings per share: 0.25 yuan [1]

博士眼镜连锁股份有限公司 2025 年半年度财务报告 一、审计报告 半年度报告是否经过审计 □是 否 公司半年度财务报告未经审计。 二、财务报表 财务附注中报表的单位为：元 1、合并资产负债表 编制单位：博士眼镜连锁股份有限公司 3 2、母公司资产负债表 2025 年 06 月 30 日 单位：元 项目 期末余额 期初余额 流动资产： 货币资金 191,123,716.47 199,335,621.73 结算备付金 拆出资金 交易性金融资产 168,544,420.08 128,146,988.11 衍生金融资产 应收票据 应收账款 85,638,536.64 75,979,279.51 应收款项融资 预付款项 9,480,797.86 44,338,414.75 应收保费 应收分保账款 应收分保合同准备金 其他应收款 53,293,227.53 51,671,950.04 其中：应收利息 应收股利 买入返售金融资产 存货 226,001,725.80 186,463,335.97 其中：数据资源 合同资产 1 | 持有待售资产 | | | | --- | --- | --- | | 一年内到期的非流动资产 ...

博士眼镜连锁股份有限公司 2025 年半年度非经营性资金占用及其他关联资金往来情况汇总表 单位：元 | 非经营性资金 | 资金占用方名 | 占用方与 上市公司 | 上市公 司核算 | 2025 年度期初 | 2025 半年度占 | 2025 半 年度占 | 2025半年度偿 | 2025 半年度期末 | 占用形 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 占用 | 称 | 的关联关 | 的会计 | 占用资金余额 | 用累计发生金 额（不含利息） | 用资金 的利息 | 还累计发生金 额 | 占用资金余额 | 成原因 | 占用性质 | | | | 系 | 科目 | | | | | | | | | | | | | | | （如有） | | | | | | 控股股东、实 | | | | | | | | | | 非经营性占用 | | 际控制人及其 | | | | | | | | | | 非经营性占用 | | 附属企业 | | | | | | | | | | 非经营性占用 | | 小计 | — | — | — | | ...

证券代码：300622 证券简称：博士眼镜 公告编号：2025-058 博士眼镜连锁股份有限公司 关于聘任证券事务代表的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 博士眼镜连锁股份有限公司（以下简称"公司"）于 2025 年 8 月 26 日召开 第五届董事会第十五次会议，审议通过了《关于聘任证券事务代表的议案》，同 意聘任陈芊芊女士为公司证券事务代表，协助公司董事会秘书履行职责，任期自 董事会审议通过之日起至第五届董事会任期届满之日止。 陈芊芊女士已取得深圳证券交易所颁发的董事会秘书资格证书，具备履行职 责所必需的专业知识和相关工作经验，其任职资格符合《深圳证券交易所创业板 股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号—创业板上市公 司规范运作》等相关法律法规和规范性文件的规定。陈芊芊女士的简历详见附件。 公司证券事务代表的联系方式如下： 附件：陈芊芊女士简历 陈芊芊女士，1992 年出生，本科学历，中国国籍，无永久境外居留权，毕 业于武汉工程大学，取得会计学学士学位，国际注册内部审计师（CIA），已取 得深圳证券交易所董事会秘书资 ...

证券代码：300622 证券简称：博士眼镜 公告编号：2025-056 博士眼镜连锁股份有限公司 第五届监事会第十三次会议决议公告 具体内容详见公司同日披露于巨潮资讯网（www.cninfo.com.cn）的《2025 年半年度报告》及《2025 年半年度报告摘要》。 2、审议通过了《关于注销 2021 年限制性股票与股票期权激励计划首次授予 股票期权第三个行权期满未行权股票期权的议案》 本公司及监事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 博士眼镜连锁股份有限公司（以下简称"公司"）第五届监事会第十三次会 议通知于 2025 年 8 月 15 日以电子邮件的形式发出，会议于 2025 年 8 月 26 日上 午 11:30 在公司会议室以现场结合通讯表决方式召开。本次会议应参与表决监事 3 人，实际参与表决监事 3 人。会议由监事会主席杨晓民先生召集和主持，董事 会秘书丁芸洁女士列席会议。本次会议的召开符合有关法律、行政法规、部门规 章、规范性文件和《公司章程》的规定。 二、监事会会议审议情况 1、审议通过了《关于<2025 年半年度报告> ...